您的购物车当前为空
别名 UNII-Q7ZOK859UK, Tofacitinib metabolite M2, CP-690,550A
Cp-690550a is a novel JAK3 inhibitor, which is used to treat rheumatoid arthritis, graft rejection, psoriasis, and other immune-mediated diseases.

Cp-690550a is a novel JAK3 inhibitor, which is used to treat rheumatoid arthritis, graft rejection, psoriasis, and other immune-mediated diseases.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | ¥ 10,600 | 6-8周 | |
| 50 mg | ¥ 13,800 | 6-8周 | |
| 100 mg | ¥ 17,500 | 6-8周 |
CP-690550A 相关产品
| 产品描述 | Cp-690550a is a novel JAK3 inhibitor, which is used to treat rheumatoid arthritis, graft rejection, psoriasis, and other immune-mediated diseases. |
| 别名 | UNII-Q7ZOK859UK, Tofacitinib metabolite M2, CP-690,550A |
| 分子量 | 303.36 |
| 分子式 | C15H21N5O2 |
| CAS No. | 1243290-37-0 |
| 密度 | 1.326 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容